- Pulse Disruption
- Posts
- Future Jobs in Healthcare
Future Jobs in Healthcare
Unveiling Brain Foundation Models, Minimally Invasive Heart Solutions, HIPAA Compliance Automation, and Cancer's Immune System Assault

Unveiling the Future of Healthcare: Your Weekly Chronicle of Health Tech Innovation
👋🏼 Healthcare Innovators ❤️
Thank you for being an incredible subscriber! Next week, we'll be delivering two issues of Pulse Disruption due to the abundance of health tech news. We hope you enjoy them!
👉🏼 Here in case you missed last week edition: Paving the Way for Tuition-Free Education

🌐 Healthcare | News
Future Jobs in Healthcare: Embracing Opportunities Amidst Technological Revolution
Anticipating the transformative effects of the ongoing technological revolution in healthcare, several new job opportunities are predicted to emerge by 2040. Embracing these changes as opportunities rather than threats, individuals adapting to these roles are likely to become the beneficiaries of this revolution. Some envisioned future healthcare jobs include:
Robot Companion Technician: With the rise of robotic companions, technicians will be in demand to repair and maintain these AI-driven companions, ensuring they function optimally and provide necessary support.
Deep Learning Expert Training Algorithms: As AI continues to play a significant role in healthcare decision-making, experts in training deep learning algorithms will be crucial in enhancing AI's ability to learn autonomously, contributing to more accurate medical assessments.
Generative AI Chatbot Designer: Professionals specializing in designing AI-driven chatbots, equipped with generative capabilities, will be essential as AI chatbots become pervasive in providing medical assistance and information.
Lifestyle Strategist: With the proliferation of health and fitness wearables, lifestyle strategists will guide individuals in selecting suitable devices, creating personalized lifestyle plans, and offering advice on health insurance and wearable technologies.
Bioprinting Organ Designer: Focused on 3D bioprinting of organs, these specialists will be in high demand as technology progresses, providing solutions to the growing demand for organ transplants.
Healthcare Navigator: Collaborating with large language models, healthcare navigators will assist patients in finding optimal solutions to their health issues, presenting options, and forwarding relevant information to caregivers.
Healing Gamification Specialist: Experts in incorporating gamification into healthcare, particularly through virtual reality and augmented reality, will design personalized games to aid in patients' treatment plans and rehabilitation.
Augmented/Virtual Reality Operation Planners: Assisting surgeons in complex operations, these professionals will use AR/VR technologies to visualize and plan surgical interventions extensively.
Digital Health Security Analyst: With the increasing reliance on digital technologies in healthcare, security analysts will specialize in safeguarding patient data, health apps, and medical devices from cyber threats.
End-of-Life Therapist: Addressing the changing attitudes toward death, these psychologists will assist individuals in preparing for death, offering support to those considering voluntary death, and helping individuals explore alternative options, such as synthetic life through consciousness uploading.
Adapting to these evolving roles presents an opportunity for individuals to contribute to and thrive in the dynamic landscape of future healthcare.

💰 Healthcare | Startups
Innovative Biotech Startup, Insamo, Aims to Transform Biologics into Oral Medications

Tim Craven, Insamo CEO
Berkeley-based biotech startup Insamo, established in 2022, recently secured $12 million in seed funding from investors such as venBio and Playground Global. Led by a team of PhD scientists, Insamo focuses on developing macrocyclic peptides, ring-shaped mini-proteins with the potential of antibody drugs but small enough to be taken orally. The startup's approach involves extensive screening of trillions of molecules, offering a unique advantage in designing orally available drugs. While the company has conducted early research on proteins TNFR1 and IL4R, mirroring targets of blockbuster drugs like Humira and Dupixent, CEO Tim Craven emphasized their commitment to advancing cyclic peptides towards clinical applications. Read More
Abridge Secures $150M in Series C to Revolutionize Clinical Documentation

Image provided by https://medriva.com/
Clinical documentation company Abridge has successfully raised $150 million in a Series C funding round, following its Series B raise last fall. The substantial funding highlights the growing interest in ambient tech companies focused on alleviating the note-taking burden for healthcare professionals. Led by Lightspeed Venture Partners and Redpoint Ventures, with participation from CVS Health Ventures and others, Abridge plans to utilize the funds for researching potential use-cases, recruiting academics, and expanding its team of machine learning engineers. The Pittsburgh-based company, known for its proprietary large-language model and speech recognition technology, aims to enhance electronic health records (EHR) and improve overall clinical documentation. While facing competition, including market giant Nuance, Abridge and similar companies are at the forefront of developing technological solutions to address challenges posed by legacy EHR technology in the healthcare sector. Read More
Phagenesis Secures $42M in Series D to Advance Dysphagia Treatment

Image Provided by Phagenesis
Phagenesis, the developer of an FDA-approved dysphagia neurostimulation system named Phagenyx, has successfully raised $42 million in a Series D financing round. Led by EQT Life Sciences and Sectoral, with participation from new backers such as British Patient Capital, Northern Gritstone, and Aphelion, the funds will be allocated to U.S. commercialization efforts, supporting clinical trials, and collecting real-world data for long-term reimbursement in the U.S. market. Phagenyx aims to address swallowing dysfunction caused by brain injuries, such as strokes, with a focus on restoring swallowing coordination and control. The Manchester-based company plans to secure reimbursement through the New Technology Add-On Payments (NTAP) pathway, highlighting its commitment to tackling dysphagia, a condition linked to prolonged hospital stays and increased complications. Read More

🚀 YC Launches
Piramidal is developing a brain foundation model trained on EEG data to understand and detect various facets of brain activity, focusing on neurological conditions. The first product is a co-pilot for epilepsy diagnosis, aiming to provide real-time insights, reduce diagnostic time, and minimize errors in EEG analysis. Founders Dimitris and Kris bring expertise in neuroscience, AI, and product development to the project.
Selera Medical is developing a minimally invasive device for chronic heart failure that leverages the body's fluid management system to offload trapped fluid, reducing symptoms and hospitalizations. The founders, Stacie Arechavala and Kevin Bui, aim to address the limited and ineffective treatment options for heart failure patients, offering a one-time procedure with sustained effects.
Delve offers a fast track to HIPAA compliance by automating infrastructure, streamlining paperwork, and providing real-time monitoring. Founded by MIT-trained founders Karun Kaushik and Selin Kocalar, Delve aims to simplify the compliance process for companies handling sensitive health data in accordance with the Health Insurance Portability and Accountability Act (HIPAA).
Granza Bio, founded by two PhD graduates in Oncology and Immunology from the University of Oxford, is developing personalized and targeted cancer treatments using engineered "attack particles" derived from the immune system. These particles selectively target and kill cancer cells, offering a solution to the problem of ineffective treatments with unwanted side effects in approximately 50% of cancer patients.

🧠 Healthcare | AI | Tech
Veradigm Accelerates Healthcare Intelligence with ScienceIO Acquisition

Image provided by Getty
Veradigm, a leading healthcare data and technology provider, is set to acquire ScienceIO, a prominent AI platform for healthcare. This strategic move aims to leverage ScienceIO's AI capabilities on Veradigm's extensive data set, fostering the development of advanced language models for healthcare. The acquisition is anticipated to propel Veradigm's growth, enhance customer experience across its business units, and position the company as a leader in healthcare data intelligence. The integration of ScienceIO's platform is expected to deliver valuable insights, improve outcomes, and establish Veradigm as a higher-margin technology and data products company. Read More
AI Revolutionizes Prosthetic Eyes: 3D Printing and Artificial Intelligence Cut Production Time by 80%

A man with a prosthetic right eye, which was not created via the AI approach Imagee By: Stephen Bell, Ocupeye Ltd.
Artificial intelligence (AI) is revolutionizing the creation of prosthetic eyes through a 3D printing process, significantly reducing the time needed compared to traditional methods. This innovative approach, using an AI model and a 3D printer, streamlines the production of prosthetic eyes, potentially increasing accessibility for a broader population. The traditional method involves highly trained ocularists taking molds of the eye socket, a time-consuming process. The AI-designed and 3D-printed prosthetic eyes not only save time but also demonstrate promising results in achieving well-fitting implants, according to a small trial. This advancement has the potential to benefit a larger number of individuals who require prosthetic eyes. Read More
Hal: Revolutionizing Health Education with AI Mannequin at Husson University
Husson University in Bangor, Maine, introduces Hal, an AI mannequin, at its Simulated Education Center, marking a new era in healthcare simulation. Hal, equipped with artificial intelligence, simulates realistic patient scenarios, exhibiting movements, speech, sweating, and even crying. This immersive learning tool allows health students to practice and enhance their skills in a lifelike environment. With 15 scenarios covering conditions like stroke and hypertension, Hal collaborates with occupational and physical therapy, pharmacy, and nursing students. Hal's lifelike interactions provide a humanized learning experience, offering students the opportunity to respond and engage with therapeutic questions. The AI mannequin, unveiled on February 13th, aligns with Husson's commitment to patient safety and quality care. Even health professionals in the community can utilize the Simulated Education Center to work with Hal, emphasizing the potential for broader applications in healthcare education. Read More

🗣️ Healthcare | Events | Conferences | March
March 8-12: SXSW Health and MedTech Track 2024 (Austin, TX)
March 11-15: 2024 HIMSS Global Health Conference (Orlando, FL)
March 11-12: Fierce BD&L Summit for Life Sciences (San Francisco, CA)
March 12-15: Health Industry Distributors Association (HIDA) Executive Conference (Amelia Island, FL)
March 12-14: AHIP 2024 Medicare, Medicaid, Duals & Commercial Markets Forum (Baltimore, MD)
March 18-20: Fierce Trial Master File Summit (Savannah, GA)
March 21: STAT 2024 Breakthrough Summit East (NYC & virtual)
March 25-28: American College of Healthcare Executives Congress on Healthcare Leadership (Chicago, IL)

That’s all for this week.
The Pulse Disruption Team
How did you like today's email? |